ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2022
Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: Commentary.
Jan Lycke et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it